SynthesisBreast cancer research and treatment2025

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis.

Vitor Teixeira Liutti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.